eResearch Technology, Inc. 

(Public, NASDAQ:ERES)   Watch this stock   
Find more results for ERES
Oct 29, 2009
Q3 2009 Earnings Conference Call
Oct 29, 2009
Q3 2009 Earnings Release
Sep 21, 2009
UBS Global Life Sciences Conference
Sep 9, 2009
Robert W. Baird & Co., Inc. Health Care Conference
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 12.40% 18.78%
Operating margin 20.72% 28.84%
EBITD margin - 39.05%
Return on average assets 7.08% 15.78%
Return on average equity 8.54% 19.93%
Employees 394 -

Address

1818 Market Street Suite 1000
Philadelphia, PA 19103
United States - Map
+1-215-9720420 (Phone)
+1-215-9720414 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

eResearch Technology, Inc. discussed on blogs

eResearch Technology, Inc. discussions

  View all discussions »

Description

eResearchTechnology, Inc. (eRT) provides technology and services that enable the pharmaceutical, biotechnology and medical device industries to collect, interpret and distribute cardiac safety and clinical data more efficiently. The Company offers centralized electrocardiographic (ECG) services (Cardiac Safety services or EXPeRT ECG services), which are used by pharmaceutical companies, biotechnology companies, medical device companies, clinical trial sponsors and clinical research organizations (CROs) during the conduct of clinical trials. It also offers site support, which includes the rental and sale of cardiac safety equipment along with related supplies and freight. The Company offers licensing and, at the client’s option, hosting of its EXPeRT eClinical software products and the provision of maintenance and consulting services in support of these products. Electronic patient reported outcomes (EXPeRT ePRO) services along with 57 clinical assessments are also offered.

Officers and directors

Joel Morganroth M.D.
Chairman of the Board, Chief Scientific Officer
Age: 63
Bio & Compensation - Reuters
Michael J. McKelvey Ph.D.
President, Chief Executive Officer, Director
Age: 56
Bio & Compensation - Reuters
Keith D. Schneck
Chief Financial Officer, Executive Vice President, Secretary
Age: 53
Bio & Compensation - Reuters
John M. Blakeley
Executive Vice President - Sales and Marketing
Age: 41
Bio & Compensation - Reuters
Jeffrey S. Litwin M.D.
Executive Vice President, Chief Medical Officer
Age: 51
Bio & Compensation - Reuters
Thomas P. Devine
Executive Vice President, Chief Development Officer
Age: 56
Bio & Compensation - Reuters
Amy Furlong
Executive Vice President - Cardiac Safety
Age: 36
Bio & Compensation - Reuters
George Tiger
Senior Vice President, Americas Sales
Age: 49
Bio & Compensation - Reuters
Robert S. Brown
Senior Vice President - Strategic Marketing, Planning & Partnerships
Age: 53
Bio & Compensation - Reuters
Sheldon M. Bonovitz
Director
Age: 71
Bio & Compensation - Reuters